Literature DB >> 13662997

The control of acid in the duodenal ulcer patient.

R C HARRISON.   

Abstract

Entities:  

Keywords:  PEPTIC ULCER/complications

Mesh:

Year:  1959        PMID: 13662997      PMCID: PMC1830900     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  Inhibition of the intestinal phase of gastric secretion by antral inhibitor substance.

Authors:  B D MARGOLUS; R C HARRISON
Journal:  Surg Forum       Date:  1957

2.  Anticholinergic drugs as used in the management of peptic ulcer; their mechanism of action and their comparative value.

Authors:  I T BECK; R D McKENNA
Journal:  Can Med Assoc J       Date:  1958-08-15       Impact factor: 8.262

3.  Inhibition of vagally stimulated gastric acid by the pyloric antrum.

Authors:  H J SHIMIZU; R T MORRISON; R C HARRISON
Journal:  Am J Physiol       Date:  1958-09

4.  The production of an acid inhibitor by the gastric antrum.

Authors:  R C HARRISON; H A HYDE; W H LAKEY
Journal:  Ann Surg       Date:  1956-09       Impact factor: 12.969

5.  Continuously recorded in situ pH of gastric and duodenal contents in patients with and without duodenal ulcers.

Authors:  R A ROVELSTAD
Journal:  Gastroenterology       Date:  1956-11       Impact factor: 22.682

6.  The nature of gastric hypersecretion of acid in patients with duodenal ulcer.

Authors:  J N HUNT; A W KAY
Journal:  Br Med J       Date:  1954-12-18

7.  Inter relation between the cephalic and gastric phases of gastric secretion.

Authors:  L R DRAGSTEDT; H A OBERHELMAN; E R WOODWARD; C A SMITH
Journal:  Am J Physiol       Date:  1952-10

8.  Hypoglycaemia following partial gastrectomy.

Authors:  J A L GILBERT; D M DUNLOP
Journal:  Br Med J       Date:  1947-08-30

9.  HYDROGEN ION CONCENTRATION OF THE DUODENAL CONTENTS UNDER FASTING CONDITIONS IN NORMAL PERSONS AND IN PATIENTS WITH DUODENAL ULCER: A COMPARATIVE STUDY.

Authors:  R W Kearney; M W Comfort; A E Osterberg
Journal:  J Clin Invest       Date:  1941-03       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.